Abstract:One of the problems that has slowed the development and approval of new anticancer therapies is the lack of preclinical models that can be used to identify key molecular, cellular and biophysical features of human cancer progression. This is because most in vitro cancer models fail to faithfully recapitulate the local tissue and organ microenvironment in which tumours form, which substantially contributes to the complex pathophysiology of the disease. More complex in vitro cancer models have been developed, including transwell cell cultures, spheroids and organoids grown within flexible extracellular matrix gels, which better mimic normal and cancerous tissue development than cells maintained on conventional 2D substrates. But these models still lack the tissue–tissue interfaces, organ-level structures, fluid flows and mechanical cues that cells experience within living organs, and furthermore, it is difficult to collect samples from the different tissue microcompartments. In this Review, we outline how recent developments in microfluidic cell culture technology have led to the generation of human organs-on-chips (also known as organ chips) that are now being used to model cancer cell behaviour within human-relevant tissue and organ microenvironments in vitro. Organ chips enable experimentalists to vary local cellular, molecular, chemical and biophysical parameters in a controlled manner, both individually and in precise combinations, while analysing how they contribute to human cancer formation and progression and responses to therapy. We also discuss the challenges that must be overcome to ensure that organ chip models meet the needs of cancer researchers, drug developers and clinicians interested in personalized medicine.

Vascularized tumor-on-chip microplatforms for the studies of neovasculature as hope for more effective cancer treatments.

Recent Advances in Microfluidic Technology and Applications for Anti-Cancer Drug Screening

Advances in 3D Vascularized Tumor-on-a-Chip Technology

Microfluidic-Based 3D Engineered Microvascular Networks and Their Applications in Vascularized Microtumor Models

Tumor-on-a-chip: from bioinspired design to biomedical application

Perfusable Vessel-on-a-Chip for Antiangiogenic Drug Screening with Coaxial Bioprinting

Vascularized tumor models for the evaluation of drug delivery systems: a paradigm shift

Multilayered Modular Microfluidic Platform for 3D Vascularized Organ-on-a-chip Application

Long-term cultured microvascular networks on chip for tumor vascularization research and drug testing

The Edifice of Vasculature-On-Chips: A Focused Review on the Key Elements and Assembly of Angiogenesis Models

A Vascularized and Perfused Organ-on-a-chip Platform for Large-Scale Drug Screening Applications.

On-chip-angiogenesis Based on a High-Throughput Biomimetic Three-Dimensional Cell Spheroid Culture System.

Image-Assisted Microvessel-on-a-Chip Platform for Studying Cancer Cell Transendothelial Migration Dynamics

Personalized Vascularized Tumor Organoid-on-a-Chip for Tumor Metastasis and Therapeutic Targeting Assessment

Quantitative Phase Imaging Characterization of Tumor-Associated Blood Vessel Formation on a Chip

3D vascularized microphysiological system for investigation of tumor-endothelial crosstalk in anti-cancer drug resistance

Patient-derived tumor spheroid-induced angiogenesis preclinical platform for exploring therapeutic vulnerabilities in cancer

3D microtumors in vitro supported by perfused vascular networks

Modelling cancer in microfluidic human organs-on-chips

Tumor-microenvironment-on-a-chip: the construction and application

Engineering vascularised organoid-on-a-chip: strategies, advances and future perspectives